Cerenome
CNSY
4 hedge funds and large institutions have $8.52M invested in Cerenome in 2014 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
5.51% less ownership
Funds ownership: 21.63% → 16.12% (-5.5%)
20% less funds holding
Funds holding: 5 → 4 (-1)
37% less capital invested
Capital invested by funds: $13.5M → $8.52M (-$5M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCM
Goldman Capital Management
New York
|
-$1.36M |
| 2 |
Renaissance Technologies
New York
|
-$321K |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$45K |
| 4 |
GS
Gagnon Securities
New York
|
-$38K |
| 5 |
AC
Amici Capital
New York
|
-$27K |
CNSY Hedge Fund Activity: Q4 2014 in Review
4 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Cerenome (CNSY) for Q4 2014, worth a combined $8.52M — down 37% from $13.5M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of CNSY and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Goldman Capital Management, exiting entirely with an estimated $1.36M sold.
- 4 institutional investors held Cerenome (CNSY) as of Q4 2014, down from 5 in Q3 2014.
- Funds reported $8.52M of Cerenome stock for Q4 2014, down 37% quarter-over-quarter.
- 0 funds opened new Cerenome positions in Q4 2014 and 1 closed out, a net change of -1 holder.
- The largest Cerenome seller in Q4 2014 was Goldman Capital Management, an estimated $1.36M sold.
Based on aggregated 13F filings for Q4 2014.